Becton, Dickinson and Company (BDX) Position Trimmed by Migdal Insurance & Financial Holdings Ltd.

Migdal Insurance & Financial Holdings Ltd. lowered its position in Becton, Dickinson and Company (NYSE:BDX) by 16.3% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 1,925 shares of the medical instruments supplier’s stock after selling 374 shares during the period. Migdal Insurance & Financial Holdings Ltd.’s holdings in Becton, Dickinson and were worth $377,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of the stock. BNP Paribas Arbitrage SA boosted its holdings in Becton, Dickinson and by 18.6% in the 3rd quarter. BNP Paribas Arbitrage SA now owns 159,716 shares of the medical instruments supplier’s stock worth $29,911,000 after buying an additional 25,088 shares during the period. Suffolk Capital Management LLC bought a new position in Becton, Dickinson and in the 3rd quarter worth $10,116,000. FDx Advisors Inc. boosted its holdings in Becton, Dickinson and by 2.0% in the 3rd quarter. FDx Advisors Inc. now owns 15,557 shares of the medical instruments supplier’s stock worth $3,048,000 after buying an additional 306 shares during the period. Global X MANAGEMENT CO LLC boosted its holdings in Becton, Dickinson and by 9.8% in the 3rd quarter. Global X MANAGEMENT CO LLC now owns 4,175 shares of the medical instruments supplier’s stock worth $818,000 after buying an additional 371 shares during the period. Finally, Bessemer Group Inc. boosted its holdings in Becton, Dickinson and by 0.9% in the 3rd quarter. Bessemer Group Inc. now owns 987,226 shares of the medical instruments supplier’s stock worth $193,447,000 after buying an additional 9,176 shares during the period. 86.01% of the stock is owned by institutional investors.

In related news, EVP Linda M. Tharby sold 4,695 shares of the stock in a transaction dated Tuesday, August 22nd. The shares were sold at an average price of $200.48, for a total value of $941,253.60. Following the sale, the executive vice president now directly owns 18,670 shares of the company’s stock, valued at approximately $3,742,961.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Gary M. Cohen sold 15,512 shares of the stock in a transaction dated Monday, September 11th. The stock was sold at an average price of $203.77, for a total transaction of $3,160,880.24. Following the completion of the sale, the insider now directly owns 95,781 shares in the company, valued at $19,517,294.37. The disclosure for this sale can be found here. In the last ninety days, insiders sold 47,038 shares of company stock valued at $9,480,225. 1.40% of the stock is owned by insiders.

BDX has been the subject of several research reports. Royal Bank Of Canada reissued a “hold” rating and set a $210.00 price objective on shares of Becton, Dickinson and in a report on Wednesday, October 25th. Zacks Investment Research downgraded shares of Becton, Dickinson and from a “hold” rating to a “sell” rating in a report on Monday, October 9th. Stifel Nicolaus reissued a “buy” rating and set a $245.00 price objective on shares of Becton, Dickinson and in a report on Friday, November 3rd. Morgan Stanley increased their price objective on shares of Becton, Dickinson and from $205.00 to $245.00 and gave the company an “equal weight” rating in a report on Friday, November 3rd. Finally, Wells Fargo & Company reissued a “positive” rating and set a $235.00 price objective (up previously from $225.00) on shares of Becton, Dickinson and in a report on Tuesday, October 24th. They noted that the move was a valuation call. Five research analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. Becton, Dickinson and has an average rating of “Buy” and a consensus target price of $213.47.

TRADEMARK VIOLATION WARNING: “Becton, Dickinson and Company (BDX) Position Trimmed by Migdal Insurance & Financial Holdings Ltd.” was first posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright legislation. The correct version of this news story can be read at https://sportsperspectives.com/2017/11/14/becton-dickinson-and-company-bdx-position-trimmed-by-migdal-insurance-financial-holdings-ltd.html.

Becton, Dickinson and Company (NYSE BDX) opened at $220.00 on Tuesday. The company has a debt-to-equity ratio of 1.48, a current ratio of 5.56 and a quick ratio of 5.01. Becton, Dickinson and Company has a 1-year low of $161.29 and a 1-year high of $225.23. The company has a market cap of $49,889.07, a PE ratio of 23.10, a P/E/G ratio of 1.72 and a beta of 1.04.

Becton, Dickinson and (NYSE:BDX) last announced its quarterly earnings results on Thursday, November 2nd. The medical instruments supplier reported $2.40 EPS for the quarter, beating the Zacks’ consensus estimate of $2.37 by $0.03. Becton, Dickinson and had a net margin of 8.52% and a return on equity of 22.51%. The firm had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.14 billion. During the same quarter last year, the firm earned $2.12 EPS. The firm’s revenue for the quarter was down 2.0% compared to the same quarter last year. research analysts expect that Becton, Dickinson and Company will post 10.63 earnings per share for the current year.

Becton, Dickinson and Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply